Neuropeptide FF receptors of mouse olfactory bulb: Binding properties and stimulation of adenylate cyclase activity

Peptides

Volumn 18, Issue 4, 1997, Pages 577-583

  Gherardi, Nathalie ^a   Zajac, Jean Marie ^a  

^a CNRS   (France)

Author keywords

Adenylate cyclase; cAMP; Mouse; Neuropeptide FF; Olfactory bulb; Receptors

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; IODINE 125; NEUROPEPTIDE FF; NEUROPEPTIDE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RECEPTOR BINDING; SPINAL CORD;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; GUANYLYL IMIDODIPHOSPHATE; KINETICS; MAGNESIUM CHLORIDE; MALE; MEMBRANES; MICE; OLFACTORY BULB; RADIOLIGAND ASSAY; RECEPTORS, NEUROPEPTIDE; SODIUM CHLORIDE; STIMULATION, CHEMICAL;

ANIMALIA;

EID: 0031006124     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00071-5     Document Type: Article

References (38)

1. Allard M., Geoffre S., Legendre P., Vincent J. D., Simonnet G. Characterisation of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: A binding study. Brain Res. 500:1989;169-176.
2. Allard M., Jordan D., Zajac J.-M., Ries C., Martin D., Monkouanga D., Kopp N., Simonnet G. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;127-132.
3. Allard M., Theodosis D. T., Rousselot P., Lombard M. C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide in the rat spinal cord: Biochemical and immunocytochemical studies. Neuroscience. 40:1991;81-92.
4. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine modulating peptide in rat central nervous system. Neuroscience. 49:1992;101-116.
5. Alvarez R., Daniels D. V. A single column method for the assay of adenylate cyclase. Anal. Biochem. 187:1990;98-103.
6. + and GTP. Proc. Natl. Acad. Sci. USA. 76:1979;5626-5630.
7. Bradford M. M. A rapid and sensitive method for the quantification of micrograms of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72:1976;248-254.
8. Desprat C., Zajac J.-M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
9. Devillers J.-P., Mazarguil H., Allard M., Dickenson A. H., Zajac J.-M., Simonnet G. Characterization of a potent agonist for NPFF receptors: Binding study on rat spinal cord. Neuropharmacology. 33:1994;661-669.
10. Donlon M. A. a. W. R. I. Adenyl cyclase activity of mouse liver membranes after incubation with endotoxin and epinephrine. Specialia Experientia. 32:1976;179-181.
11. 2]Deltorphin-I: A high-affinity delta-selective opioid receptor ligand. Peptides. 12:1991;825-830.
12. Dupouy V., Pujet A., Eschalier A., Zajac J.-M. Species differences in the localization of neuropeptide FF receptors in rodent and lagomorph brain and spinal cord. Peptides. 17:1996;399-405.
13. Gicquel S., Fioramonti J., Bueno L., Zajac J.-M. Effects of F8Famide analogs on intestinal transit in mice. Peptides. 14:1993;749-753.
14. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
15. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.-P., Simonnet G., Zajac J.-M. Structure activity study of Neuropeptide FF: Contribution of N-terminal regions to affinity and activity. J. Med. Chem. 37:1994;3477-3481.
16. Gouardères C., Jhamandas K., Sutak M., Zajac J.-M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
17. Gouardères C., Sutak M., Zajac J.-M., Jhamandas K. Antinociceptive effects of intrathecally administred F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
18. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci. Lett. 155:1990;307-312.
19. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
20. Kivipelto L., Majane E. A., Yang H.-Y. T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
21. Lake J. R., Hammond M. V., Shaddox R. C., Hunsicker L. M., Yang H.-Y. T., Malin D. H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132:1991;29-32.
22. 2-like peptides in spinal cords of various mammalian species using specific radioimmunoassay. Peptides. 9:1988;1137-1144.
23. 2-like precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
24. Malin D. H., Lake J. R., Short P. E., Blossman J. B., Lawless B. A., Schopen C. K., Sailer E. E., Burgess K., Wilson O. B. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. 54:1996;581-583.
25. Margiotta J. F. a. P. D. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity. Mol. Pharmacol. 48:1995;63-71.
26. Mukherjee C., Lefkowitz R. J. Desensitization of β -adrenergic receptors by β -adrenergic agonists in a cell-free system: Resensitization by guanosine 5′-( β , γ -imino) triphosphate and other purine nucleotides. Proc. Natl. Acad. Sci. USA. 73:1976;1494-1498.
27. Oberling P., Stinus L., Moal M. L., Simonnet G. Biphasic effect on nociception and antiopiateactivity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
28. s-linked neurotransmitter receptors to stimulate adenylyl cyclase activity of rat olfactory bulb. J. Neurochem. 61:1993;2183-2190.
29. Olianas M. C., Onali P. participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase in rat olfactory bulb. J. Pharmacol. Exp. Ther. 275:1995;1560-1567.
30. Payza K., Akar C. A., Yang H.-Y. T. Neuropeptide FF receptors: Structure-activity relationship and effect of morphine. J. Pharmacol. Exp. Ther. 267:1993;88-94.
31. Payza K., Yang H.-Y. Modulation of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cord. J. Neurochem. 60:1993;1894-1899.
32. 2-related peptides on mouse colonic propulsive motility: A structure activity relationship study. J. Pharmacol. Exp. Ther. 254:1990;809-814.
33. 2+ in mouse spinal ganglion neurons. Eur. J. Pharmacol. 306:1996;291-297.
34. 3H] clonidine binding by guanine nucleotides and divalent cations. J. Neurochem. 34:1984;374-384.
35. Sharma S. K., Nirenberg M., Klee W. A. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA. 72:1975;590-594.
36. 2-like immunoreactivity. Proc. Natl. Acad. Sci. USA. 81:1984;5002-5005.
37. Wasowicz K., Panula P. Distribution of Neuropeptide FF in porcine spinal cord in comparison with other neuropeptides and serotonin. J. Comp. Neurol. 346:1994;530-540.
38. Yang H.-Y. T., Fratta W., Majane E. A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.